News

Introducing LesionID Pro* with Automated Zero-Click Pre-Processing at SNMMI

Introducing LesionID Pro* with Automated Zero-Click Pre-Processing at SNMMI

A press release introducing an update of LesionID Pro* from MIM Software, a GE HealthCare Company.

June 21, 2025

Read the press release at gehealthcare.com.

*LesionID Pro with automated zero-click pre-processing is 510(k)-pending with the U.S. FDA. Not CE Marked and not licensed in accordance with Canadian law. Not available for sale in the United States, Europe, Canada, or any other region.
Theranostics Radiology and Nuclear Medicine Radiopharmaceutical Therapy Nuclear Medicine LesionID Pro
About MIM

About MIM

MIM Software, a GE HealthCare Company, makes vendor-neutral imaging software to standardize workflows in Radiation Oncology, Molecular Imaging, Theranostics, and more. Leading global healthcare organizations use MIM™ to simplify increasingly complex clinical scenarios and give patients more precise, personalized care.

Read More

MIM Expands Clinician Tools for Reirradiation and Composite Plan Assessment

October 6, 2025

A new reirradiation workflow in MIM Maestro helps visualize any number of prior EBRT plan doses on current anatomy and account for radiobiological effects.

GE HealthCare’s MIM Software Announces FDA Clearance of Monte Carlo Dosimetry for Theranostics

October 9, 2024

A press release announcing that GE HealthCare’s MIM Software has received FDA clearance of a new Centiloid scaling tool in MIMneuro®.

GE HealthCare's MIM Software Announces FDA Clearance of New Centiloid Scaling Tool to Quantify Amyloid Plaque in Brain Imaging

September 17, 2024

A press release announcing that GE HealthCare’s MIM Software has received FDA clearance of a new Centiloid scaling tool in MIMneuro®.

Send Me More Information Arrow